This inventor holds 25 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Sulfonamide Derivatives. Top assignee: Eli Lilly and Company. Active years: 1998-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2010
Areas of Expertise:
Title: Innovator Spotlight: Hamideh Zarrinmayeh - Pioneering Pharmaceutical Research
Introduction: Hamideh Zarrinmayeh, a distinguished inventor based in Carmel, Indiana, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 25 patents. His groundbreaking work has focused on developing compounds to treat a range of neurodegenerative and psychiatric disorders, showcasing his dedication to improving healthcare outcomes.
Latest Patents: Among his latest patents are innovative compounds designed to address conditions such as schizophrenia, cognitive deficits associated with schizophrenia, Alzheimer's disease, dementia of the Alzheimer's type, mild cognitive impairment, and depression. Specifically, Zarrinmayeh's inventions include thiophene and furan compounds as well as pyrrole and pyrazole derivatives that act as potentiators of glutamate receptors, particularly AMPA and the GluR family.
Career Highlights: Hamideh Zarrinmayeh is currently affiliated with Eli Lilly and Company, a renowned pharmaceutical corporation known for its cutting-edge research and development in the healthcare sector. His tenure at Eli Lilly and Company underscores his commitment to fostering innovation and driving advancements in pharmaceutical sciences to address unmet medical needs.
Collaborations: Throughout his career, Zarrinmayeh has collaborated with esteemed professionals in the field, including Dennis Michael Zimmerman and Paul Leslie Ornstein. Together, they have shared insights, expertise, and a passion for developing novel therapeutic solutions that have the potential to transform patient care and outcomes.
Conclusion: In conclusion, Hamideh Zarrinmayeh stands out as a visionary inventor at the forefront of pharmaceutical innovation. His inventive spirit, coupled with his relentless pursuit of scientific excellence, continues to shape the landscape of healthcare interventions, offering hope and healing to individuals affected by challenging medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile